Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb;15(2):209-17.
doi: 10.2174/1389200215666140130124910.

Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process

Kelly E Caudle, Teri E Klein, James M Hoffman, Daniel J Muller, Michelle Whirl-Carrillo, Li Gong, Ellen M McDonagh, Katrin Sangkuhl, Caroline F Thorn, Matthias Schwab, Jose A G Agundez, Robert R Freimuth, Vojtech Huser, Ming Ta Michael Lee, Otito F Iwuchukwu, Kristine R Crews, Stuart A Scott, Mia Wadelius, Jesse J Swen, Rachel F Tyndale, C Michael Stein, Dan Roden, Mary V Relling, Marc S Williams, Samuel G Johnson  1
Affiliations
Free PMC article

Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process

Kelly E Caudle et al. Curr Drug Metab. 2014 Feb.
Free PMC article

Abstract

The Clinical Pharmacogenetics Implementation Consortium (CPIC) publishes genotype-based drug guidelines to help clinicians understand how available genetic test results could be used to optimize drug therapy. CPIC has focused initially on well-known examples of pharmacogenomic associations that have been implemented in selected clinical settings, publishing nine to date. Each CPIC guideline adheres to a standardized format and includes a standard system for grading levels of evidence linking genotypes to phenotypes and assigning a level of strength to each prescribing recommendation. CPIC guidelines contain the necessary information to help clinicians translate patient-specific diplotypes for each gene into clinical phenotypes or drug dosing groups. This paper reviews the development process of the CPIC guidelines and compares this process to the Institute of Medicine's Standards for Developing Trustworthy Clinical Practice Guidelines.

PubMed Disclaimer

References

    1. Relling M V, Klein T E. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network. Clin. Pharmacol. Therapeut. 2011;89(3):464–7. - PMC - PubMed
    1. Relling M V, Gardner E E, Sandborn W J, Schmiegelow K, Pui C H, Yee S W, Stein C M, Carrillo M, Evans W E, Klein T E. Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. Clin. Pharmacol. Therapeut. 2011;89(3):387–91. - PMC - PubMed
    1. Scott S A, Sangkuhl K, Gardner E E, Stein C M, Hulot J S, Johnson J A, Roden D M, Klein T E, Shuldiner A R. Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy. Clin. Pharmacol. Therapeut. 2011;90(2):328–32. - PMC - PubMed
    1. Johnson J A, Gong L, Whirl-Carrillo M, Gage B F, Scott S A, Stein C M, Anderson J L, Kimmel S E, Lee M T, Pirmohamed M, Wadelius M, Klein T E, Altman R B. Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin. Pharmacol. Therapeut. 2011;90(4):625–9. - PMC - PubMed
    1. Crews K R, Gaedigk A, Dunnenberger H M, Klein T E, Shen D D, Callaghan J T, Kharasch E D, Skaar T C. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype. Clin. Pharmacol. Therapeut. 2012;91(2):321–6. - PMC - PubMed

Publication types

Substances